Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members

被引:38
|
作者
Perumal-Pillay, Velisha Ann [1 ]
Suleman, Fatima [1 ]
机构
[1] Univ KwaZulu Natal, Discipline Pharmaceut Sci, Sch Hlth Sci, Westville Campus,Private Bag X54001, ZA-4000 Durban, South Africa
来源
基金
美国国家卫生研究院; 英国医学研究理事会;
关键词
Essential medicines; Essential medicines lists; Selection of essential medicines; South Africa; Standard treatment guidelines;
D O I
10.1186/s12913-016-1946-9
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The South African (SA) public health system has employed an Essential Medicines List (EML) with Standard Treatment Guidelines (STGs) in the public sector since 1996. To date no studies have reported on the process of selection of essential medicines for SA EMLs and how this may have changed over time. This study reports on the decision making process for the selection of essential medicines for SA EMLs, over the years, as described by various members of the National Essential Medicines List Committee (NEMLC) and their task teams. Methods: Qualitative in-depth interviews, guided by an interview questionnaire, were conducted with 11 members of the SA NEMLC and their task teams (both past and present members) during the period January - April 2015. Interviews were recorded and transcribed verbatim. Transcripts were then coded by the first author and verified by the second author before being reconciled and input into NVIVO, a qualitative software, to facilitate analysis of the data. Results: The interviews conducted suggest that the NEMLC process of medicine selection has been refined over the years. This together with the EML review process is now essentially predominantly an evidence based process where quality, safety and efficacy of a medicine is considered first followed by cost considerations which includes pharmacoeconomic evaluations, and pricing of medicines. Conclusions: This is the first study in SA to report on how decisions are taken to include or exclude medicines on SA national EMLs and provides insight into the SA EML medicine selection, review and monitoring processes over time. The results show that the NEMLC has undergone tremendous transformation over the years. Whilst the membership of the committee largely remains unchanged, the committee has developed its policies and processes over the years. However there is still a need to strengthen the monitoring and evaluation aspects of the SA EML policy process.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
    Velisha Ann Perumal-Pillay
    Fatima Suleman
    [J]. BMC Health Services Research, 17
  • [2] A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
    Mustafa, Asma Abubakr
    Kowalski, Stefan Robert
    [J]. LIBYAN JOURNAL OF MEDICINE, 2010, 5
  • [3] Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list
    Maraj, Darshanand
    Steiner, Liane
    Persaud, Nav
    [J]. JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2022, 27
  • [4] Selection of Essential Medicines in South Africa - A Work in Progress
    Leong, T. D.
    Munsamy, J.
    Reddy, M.
    Gray, A.
    [J]. SA PHARMACEUTICAL JOURNAL, 2015, 82 (03) : 39 - 41
  • [5] Evidence and essential medicines: the selection,evaluation and continuation of a medicines list
    Phil Wiffen
    [J]. 中国循证医学杂志, 2003, (02) : 83 - 86
  • [6] Integrating obesity medicines in the national list of essential medicines: a policy concern
    Sindhwani, Ritika
    Bora, Kundan Singh
    Hazra, Subhajit
    [J]. Current Science, 2024, 127 (06): : 660 - 661
  • [7] The Selection and Use of Essential Medicines Report of the WHO Expert Committee, 2017 (including the 20th WHO Model List of Essential Medicines and the 6th WHO Model List of Essential Medicines for Children)
    [J]. SELECTION AND USE OF ESSENTIAL MEDICINES: REPORT OF THE WHO EXPERT COMMITTEE, 2017 (INCLUDING THE 20TH WHO MODEL LIST OF ESSENTIAL MEDICINES AND THE 6TH WHO MODEL LIST OF ESSENTIAL MEDICINES FOR CHILDREN), 2017, 1006 : I - +
  • [9] National list of essential medicines of India: The way forward
    Manikandan, S.
    Gitanjali, B.
    [J]. JOURNAL OF POSTGRADUATE MEDICINE, 2012, 58 (01) : 68 - 72
  • [10] The interpretation of China national essential medicines list 2018
    Zuo, Wei
    Mei, Dan
    Sun, Wenjuan
    Tang, Xiaowan
    Niu, Ziran
    Gao, Daihui
    Zhang, Bo
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (02) : 191 - 200